Coronavirus (Covid-19): Latest updates and information
Skip to main content Skip to navigation

Early Career Fellows

"Some of these challenges have opened the door to completely new ventures."

 Dr Eva Caamano, ECF Blog: 'Exploiting pathogen's glycan adhesion for detection.'

Ross Slater:
“Exploiting pathogens – identification of a possible antimicrobial small molecule."

C.difficile, natural products, drug discovery

Christopher Thoroughgood:
"Understanding the mechanisms driving resistance to two classes of antibiotic in Enterococcus faecalis."

Target characterisation , novel inhibitors, drug discovery

Eva Caamano:
"Exploiting pathogen glycan adhesion for detection."

Diagnostics, modelling

Namrita Modgill:
"Fluorescent peptidoglycan precursors to study bacterial cell wall biosynthesis."

Target characterisation

Vincent Poon:
"Elucidating a missing gap in the biosynthesis of a novel natural compound."

Natural products, drug discovery

Paul Sazinas: 
"Bacteriophage involvement in the horizontal transfer of antimicrobial resistance genes within bacterial communities."

Phage, AMR transmission, modelling

Jasmine Desmond:
"Developing new drugs to tackle antimicrobial resistance: a combined experimental and computational approach."

Target characterisation, biophysics, modelling

Tiantian Fu:
"AMR in gut microbiota - subpopulation to single- cell resolution of swarming cells response to antibiotics."

Bacterial behaviour target characterisation, microscopy, microfluidics

Branko Rihtman:
"Double impact – exploring the potential of combined phage and antibiotic therapy."

Phage, alternatives to antibiotics, novel therapeutics

James Harrison:
"Establishment of a fluorescent resonance transfer assay (FRET) for Mycobacterium tuberculosis."

Tuberculosis method development

Shanshan Zhou:
"First X-ray crystal structure of a methylase involved in the biosynthesis of antibiotics."

Structural biochemistry. natural products, drug discovery

Alex Wilcox:
“Phagocins - a new antimicrobial concept."

Alternatives to antibiotics, novel therapeutics

Jocelyn Anstey Watkins:
"Community-level antibiotic access and use."

Behaviour, Social science, Mixed methods, modelling

George Parry:
“Cell Shaping – the impact of proximity interactions between Staphylococcus aureus and epithelial cells on infection."

Microfluidics method development, infection model

Erick Ratamero:
“Developing a 21st century alternative to penicillin: a one-drug- dual-target strategy"

Target characterisation , modelling, virtual reality

Ben Collyer:

"Towards Personalised Empirical Antibiotic Guidance – A Pilot Study"

Machine learning, modelling, public health data, clinical decision-making

Sebastien Raguideau:
"Resolving the genomic context of AMR genes from environmental metagenomes."

Environmental AMR transmission, modelling

Chris Fage:
“Exploiting carbene-based footprinting."

Drug discovery method development, biosynthetic pathway engineering

Jessica Furner-Pardoe:
"Cytotoxicity & immunomodulatory activity of an 'ancientbiotic.'"

Alternatives to antibiotics

Kathryn Styles:
“Flexicates: novel chemical entities with novel modes of action."

Drug discovery, Alternatives to antibiotics